Literature DB >> 13958401

Decreased activities of liver microsomal drug-metabolizing enzymes in the rats bearing Walker carcinosarcoma.

R KATO, G FRONTINO.   

Abstract

Entities:  

Keywords:  CARCINOMA 256, WALKER; HEXOBARBITAL; LIVER; MEPROBAMATE; STRYCHNINE

Mesh：

Substances：

Year:  1963        PMID： 13958401     DOI： 10.1007/BF02135343

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


× No keyword cloud information.
  10 in total

1.  Metabolic differences of strychnine in the rat in relation to sex.

Authors:  R KATO; E CHIESARA; P VASSANELLI
Journal:  Jpn J Pharmacol       Date:  1962-06

2.  An improved colorimetric method for the determination of meprobamate in biological fluids.

Authors:  A J HOFFMAN; B J LUDWIG
Journal:  J Am Pharm Assoc Am Pharm Assoc       Date:  1959-12

3.  Influence of sex difference on the pharmacological action and metabolism of some drugs.

Authors:  R KATO; E CHIESARA; G FRONTINO
Journal:  Biochem Pharmacol       Date:  1962-03       Impact factor: 5.858

4.  Effect of tumor cell fractions upon plasma iron, liver catalase and organ weights of rats.

Authors:  R F KAMPSCHMIDT; T A McCOY
Journal:  Proc Soc Exp Biol Med       Date:  1960-04

5.  Pathways of drug metabolism.

Authors:  B B BRODIE
Journal:  J Pharm Pharmacol       Date:  1956-01       Impact factor: 3.765

6.  Purification of the liver catalase-reducing substance occurring in cancer tissues, with special reference to its activity.

Authors:  S NAKAGAWA; T KOSUGE; H TOKUNAKA
Journal:  Gan       Date:  1955-12

7.  Cytochrome oxidase in the liver of the rat bearing Walker carcinoma 256.

Authors:  A A GREENE; F L HAVEN
Journal:  Cancer Res       Date:  1957-07       Impact factor: 12.701

8.  The oxidation of drugs by liver microsomes: on the role of TPNH and oxygen.

Authors:  J R GILLETTE; B B BRODIE; B N LA DU
Journal:  J Pharmacol Exp Ther       Date:  1957-04       Impact factor: 4.030

9.  Tumor-host relations.

Authors:  R W BEGG
Journal:  Adv Cancer Res       Date:  1958       Impact factor: 6.242

10.  Mechanism of the potentiating action of beta-diethylaminoethyl diphenylpropylacetate.

Authors:  J AXELROD; J REICHENTHAL; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1954-09       Impact factor: 4.030
  10 in total
  5 in total

Review 1.  Drug disposition in pathophysiological conditions.

Authors:  Adarsh Gandhi; Bhagavatula Moorthy; Romi Ghose
Journal:  Curr Drug Metab       Date:  2012-11       Impact factor: 3.731

2.  Ultrastructural changes in rat liver cells after intramuscular implantation of a Walker tumor.

Authors:  K Kovacs; J D Khandekar; D Dardachti; B D Garg; B Tuchweber
Journal:  Experientia       Date:  1971-09-15

3.  Effects of advanced leukemia on hepatic drug-metabolizing activity in the mouse.

Authors:  G Powis; R N Harris; P J Basseches; K S Santone
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

4.  Further studies of electron transport components in a series of Morris hepatoma-bearing rats.

Authors:  S K Chattopadhyay; H D Brown; H P Morris
Journal:  Br J Cancer       Date:  1972-02       Impact factor: 7.640

Review 5.  Cancer resistance to treatment and antiresistance tools offered by multimodal multifunctional nanoparticles.

Authors:  Eudald Casals; Muriel F Gusta; Macarena Cobaleda-Siles; Ana Garcia-Sanz; Victor F Puntes
Journal:  Cancer Nanotechnol       Date:  2017-10-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.